A randomised trial on MDD patients revealed that, similar to anti-inflammatory pharmacological interventions, the effectiveness of exercise was predicted by higher baseline levels of TNF-α, and IL-1β reduction was associated with an enhancement of symptoms [169]. This evidence concerns the gene IL1B and major depressive disorder.